4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-033704
Director sold 51,581 shares at an average $11.50 ($593,428)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2016-11-15 | Sale | −33,064 | $11.48 | $379,476 | 3,811,317 | I |
| Canaan IX L.P. Director | 2016-11-16 | Sale | −18,517 | $11.55 | $213,953 | 3,792,800 | I |
| Open-market sales · 51,581 sh · avg $11.50 · $593,428 | |||||||
Loading xslF345X03/doc4.xml…